OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 99 filers reported holding OPHTHOTECH CORP in Q1 2017. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $0 | – | 300 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 300 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | -50.0% | 300 | -44.8% | 0.00% | – |
| Q4 2016 | $2,000 | -94.6% | 543 | -31.4% | 0.00% | -100.0% |
| Q3 2016 | $37,000 | +37.0% | 791 | +52.1% | 0.00% | – |
| Q2 2016 | $27,000 | +12.5% | 520 | -5.3% | 0.00% | – |
| Q1 2016 | $24,000 | -46.7% | 549 | -4.5% | 0.00% | -100.0% |
| Q4 2015 | $45,000 | +2150.0% | 575 | +784.6% | 0.00% | – |
| Q3 2015 | $2,000 | -50.0% | 65 | -8.5% | 0.00% | – |
| Q2 2015 | $4,000 | -33.3% | 71 | -37.7% | 0.00% | – |
| Q1 2015 | $6,000 | +50.0% | 114 | +44.3% | 0.00% | – |
| Q4 2014 | $4,000 | – | 79 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
| Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
| Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
| JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
| AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
| Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
| IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
| Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
| Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
| WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |